Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma
Author:
Affiliation:
1. Concord Hospital; Sydney New South Wales Australia
2. School of Pathology and Laboratory Medicine; University of Western Australia; Crawley Western Australia Australia
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12732/fullpdf
Reference17 articles.
1. Sentinel Lymph Node Biopsy for Mellanoma;Menzies;Br. Med. J.,2015
2. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma;Azimi;J. Clin. Oncol.,2012
3. Final version of 2009 AJCC melanoma staging and classification;Balch;J. Clin. Oncol.,2009
4. Sentinel-node biopsy or nodal observation in melanoma;Morton;N. Engl. J. Med.,2014
5. Response to ‘No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report’;Faries;Br. J. Dermatol.,2015
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?;Annals of Surgical Oncology;2022-10-06
2. Impact of the time interval between primary melanoma excision and sentinel node biopsy: A systematic review and meta-analysis;Journal of the American Academy of Dermatology;2021-07
3. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor;Annals of Oncology;2021-03
4. Biopsia selectiva del ganglio centinela en melanoma: ni utilidad terapéutica, ni es buena para seleccionar los pacientes que podrían beneficiarse de la inmunoterapia adyuvante;Actas Dermo-Sifiliográficas;2020-07
5. Sentinel Lymph Node Biopsy Has No Therapeutic Value in Melanoma and Is Not Useful for Selecting Patients Who Could Benefit From Adjuvant Immunotherapy;Actas Dermo-Sifiliográficas (English Edition);2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3